Pharmaceutical Industry Information Portal

HomeRegulatory News

Regulatory News

Pfizer pulls blood pressure med in Canada on carcinogen fears

Pfizer is pulling 15 lots of its long-acting blood pressure med Inderal from Canadian shelves, citing unacceptable nitrosamine levels across a range of product...

EU adopts a common standard for the electronic product information on medicines

The European Medicines Regulatory Network has adopted a Common Standard for the electronic product information (ePI) on medicines in the European Union (EU). The EU...

FDA approves Agios’ mitapivat as first disease-modifying therapy for genetic blood disorder

Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism pioneering therapies for genetically defined diseases, announced that the U.S. Food and Drug...

The EAEU has established uniform rules for the circulation of veterinary drugs

The Council of the Eurasian Economic Commission (EEC) approved new rules on regulation of veterinary drugs circulation in the territory of the EAEU Customs...

Nuvaxovid is the first protein-based COVID-19 vaccine authorized in UK

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Medicines and Healthcare products...

Rosselkhoznadzor removed the veterinary drug “Telazol 100 mg” from the list of prohibited

Rosselkhoznadzor announced that a veterinary drug Telazol 100 mg has been allowed to be imported into Russia. The decision comes after Rosselkhoznadzor has confirmed the...
spot_img

Expert Articles

spot_img